CGAS and hepatocellular carcinoma: These results thus indicate that although HBV DNA is competent to activate cGAS-STING pathway (Figure 2), the enhanced mature nucleocapsid disassembly in the cytoplasm by GLS4 treatment or CpI126A mutation is insufficient to activate this DNA sensor pathway in human hepatoma cells (Figure 3).